RecruitingNot ApplicableNCT06275412

Family Intervention for Black Teens With Type 1 Diabetes

Family mHealth Intervention to Improve Health Outcomes in Black Youth With Type 1 Diabetes


Sponsor

Wayne State University

Enrollment

216 participants

Start Date

Sep 16, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to conduct a multicenter, randomized effectiveness trial of The 3Ms 2.0 compared to an educational control condition for improving adolescent glycemic control and diabetes-related family relationships and reducing primary caregiver diabetes-related distress among Black adolescents with type 1 diabetes (T1D) and their primary caregivers. The proposed study would develop and test The 3Ms 2.0 adapted intervention when delivered using a mobile health approach (accessed via parents' cell phone). The intervention will also include new family intervention content (videoclips and text messages).


Eligibility

Min Age: 10 YearsMax Age: 14 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a family-based support program to help Black children and teenagers with Type 1 diabetes manage their blood sugar levels better. The program involves both the child and their parent or caregiver. **You may be eligible if...** - Your child is between 10 and 14 years old - Your child has been diagnosed with Type 1 diabetes for at least 6 months - Your child identifies as Black - A parent or primary caregiver is willing to participate - You live within 30 miles of a recruitment site - You have a smartphone, tablet, or computer with internet access **You may NOT be eligible if...** - Your child has a serious mental health condition that could affect the study data (e.g., schizophrenia, developmental delay) - Your child has another medical condition that complicates their diabetes management (e.g., cystic fibrosis) - Your child or family cannot communicate in English - Your child is currently living outside the home (e.g., in foster care) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALThe 3Ms 2.0 Intervention

The 3Ms is a culturally tailored, mHealth intervention for primary caregivers of Black adolescents with T1D focused on promoting daily parental monitoring of adolescent diabetes care and delivered via an Internet platform, Computer Intervention Authoring System (CIAS). The intervention content is based on the Information-Motivation-Behavioral Skills (IMB) model. Caregivers randomized to The 3Ms receive 3 sessions. The caregiver is guided through each session by an interactive and emotive three-dimensional narrator that reads and speaks aloud. Additional intervention content includes brief videoclips to provide skills demonstrations of supportive parenting practices related to diabetes care and text message reminders. Each session is no more than 20 minutes in length. The intervention is delivered over a three-month window, with the two follow-up sessions available to be accessed by the caregiver at one-month intervals after completion of the initial session.

BEHAVIORALEducational Attention Control (EAC)

The EAC intervention consists of three sessions delivered in an mHealth format via the CIAS internet platform over three months, with access for a maximum of six months. EAC provides structured information on topics of interest to caregivers of adolescents with T1D such as travelling with diabetes, or emergency preparedness for persons with diabetes. All participants receive their standard medical care.


Locations(4)

Children's National Hospital

Washington D.C., District of Columbia, United States

Wayne Pediatrics

Detroit, Michigan, United States

LeBonheur Children's Hospital

Memphis, Tennessee, United States

University of Tennessee Health Science Center-Memphis

Memphis, Tennessee, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06275412


Related Trials